Chargement en cours...
Immune Effects of Bevacizumab: Killing Two Birds with One Stone
Angiogenesis or new vessel formation is essential for tumour growth and progression. Therefore, targeting angiogenesis has been an attractive strategy in the treatment ofcancer. Bevacizumab is a recombinant humanized monoclonal IgG1 antibody thattargets vascular endothelial growth factor-A (VEGF-A)...
Enregistré dans:
| Publié dans: | Cancer Microenviron |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Netherlands
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4449343/ https://ncbi.nlm.nih.gov/pubmed/25326055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12307-014-0160-8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|